doxapram has been researched along with Child Development Deviations in 2 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was a marked difference in the cumulative dosage and duration of doxapram therapy used for apnea of prematurity (total dose 2233 +/- 1927 mg vs 615 +/- 767 mg, P < ." | 7.71 | Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. ( Demianczuk, N; Etches, PC; Robertson, CM; Sreenan, C, 2001) |
| " There was a marked difference in the cumulative dosage and duration of doxapram therapy used for apnea of prematurity (total dose 2233 +/- 1927 mg vs 615 +/- 767 mg, P < ." | 3.71 | Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea. ( Demianczuk, N; Etches, PC; Robertson, CM; Sreenan, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lando, A | 1 |
| Klamer, A | 1 |
| Jonsbo, F | 1 |
| Weiss, J | 1 |
| Greisen, G | 1 |
| Sreenan, C | 1 |
| Etches, PC | 1 |
| Demianczuk, N | 1 |
| Robertson, CM | 1 |
2 other studies available for doxapram and Child Development Deviations
| Article | Year |
|---|---|
Doxapram and developmental delay at 12 months in children born extremely preterm.
Topics: Case-Control Studies; Developmental Disabilities; Doxapram; Female; Humans; Infant, Newborn; Infant, | 2005 |
Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
Topics: Apnea; Case-Control Studies; Cerebral Hemorrhage; Child Development; Developmental Disabilities; Dox | 2001 |